Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cabassi & Giuriati is an Italian healthcare and consumer wellness company founded in 1970 in Padua that was renamed Giuriati Group in 2021. The business develops, markets, and distributes nutritional supplements, nutraceuticals, natural cosmetics, personal care products, health items, and gluten-free foods primarily through pharmacies, parapharmacies, herbalist shops, and healthcare channels in Italy. Its core proprietary brands include Nutriva, Supravit, Nathia, Marcus Rohrer Spirulina, and more recently Nutriva Medical, while it also manages selected third-party and exclusive distribution brands. The company is commercial-stage rather than a drug-development biotech, with a portfolio focused on formulated consumer and professional health products instead of clinical pipeline assets. In 2021, private equity fund Gradiente II acquired a majority stake, and in 2023 the renamed Giuriati Group acquired Up Pharma to expand its nutraceutical and medical information footprint.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cabassi & Giuriati.